BHVN Biohaven to present new clinical data at esmo Congress on bhv-1530, a novel fgfr3-directed Adc with a proprietary topoisomerase I (topo

BHVN Biohaven to present new clinical data at esmo Congress on bhv-1530, a novel fgfr3-directed Adc with a proprietary topoisomerase I (topoix) payload